Table 2: Gender analyses.
|
Male N = 116 (%) |
Female N = 94 (%) |
|
|
Age |
|
|
|
Median (Range) |
51.3 (8-80) |
51.1 (8-92) |
|
Ethnic (p = 0.839) |
|
|
|
Chinese |
63 (54.3) |
48 (51.1) |
|
Malay |
30 (25.9) |
28 (29.8) |
|
Indian |
10 (8.6) |
6 (6.4) |
|
Others |
13 (11.2) |
12 (12.8) |
|
Site (p = 1.000) |
|
|
|
Nodal |
53 (45.7) |
43 (45.7) |
|
Extranodal |
63 (54.3) |
51 (54.3) |
|
Lymphoma Subtype |
|
|
|
DLBCL, NOS |
57 (49.1) |
50 (53.2) |
|
Plasmablastic |
2 (1.7) |
2 (2.1) |
|
FL |
14 (12.1) |
7 (7.4) |
|
MZL |
8 (6.9) |
8 (8.5) |
|
MCL |
4 (3.4) |
2 (2.1) |
|
BL |
5 (4.3) |
1 (1.1) |
|
SLL |
1 (0.9) |
2 (2.1) |
|
Lymphoblastic Lymphoma |
2 (1.7) |
1 (1.1) |
|
B-cell NHL (No category) |
5 (4.3) |
4 (4.3) |
|
T-cell NHL |
7 (6.0) |
3 (3.2) |
|
HL |
11 (9.5) |
14 (14.9) |